Group One Trading
SRNE

Group One Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Group One Trading’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-147,600
Closed -$131K – 8299
2022
Q4 		$131K Sell
147,600
-19,700
-12% -$26.1K ﹤0.01% 4198
2022
Q3 		$263K Sell
167,300
-51,200
-23% -$116K ﹤0.01% 3886
2022
Q2 		$439K Buy
218,500
+75,200
+52% +$130K ﹤0.01% 3560
2022
Q1 		$334K Sell
143,300
-122,400
-46% -$382K ﹤0.01% 4255
2021
Q4 		$1.24M Sell
265,700
-31,500
-11% -$196K ﹤0.01% 3135
2021
Q3 		$2.27M Buy
297,200
+48,600
+20% +$412K ﹤0.01% 2526
2021
Q2 		$2.41M Sell
248,600
-82,600
-25% -$658K ﹤0.01% 2440
2021
Q1 		$2.74M Sell
331,200
-402,300
-55% -$4.25M ﹤0.01% 2118
2020
Q4 		$5.01M Sell
733,500
-99,100
-12% -$796K 0.01% 1277
2020
Q3 		$9.28M Buy
832,600
+460,100
+124% +$4.21M 0.03% 560
2020
Q2 		$2.34M Buy
372,500
+237,500
+176% +$909K 0.01% 1363
2020
Q1 		$248K Sell
135,000
-115,300
-46% -$332K ﹤0.01% 2583
2019
Q4 		$846K Buy
250,300
+132,800
+113% +$317K 0.01% 2024
2019
Q3 		$251K Sell
117,500
-53,000
-31% -$124K ﹤0.01% 2922
2019
Q2 		$455K Buy
170,500
+55,000
+48% +$198K ﹤0.01% 2213
2019
Q1 		$549K Buy
115,500
+77,900
+207% +$204K 0.01% 1877
2018
Q4 		$90K Sell
37,600
-68,000
-64% -$222K ﹤0.01% 3234
2018
Q3 		$465K Sell
105,600
-367,600
-78% -$2.04M ﹤0.01% 2351
2018
Q2 		$3.41M Buy
473,200
+402,000
+565% +$2.73M 0.03% 753
2018
Q1 		$367K Buy
71,200
+65,600
+1,171% +$467K ﹤0.01% 2289
2017
Q4 		$21K Buy
+5,600
New +$14.6K ﹤0.01% 4143
2017
Q2 		– Sell
-4,700
Closed -$19K – 5232
2017
Q1 		$19K Hold
4,700
– – ﹤0.01% 3900
2016
Q4 		$23K Buy
+4,700
New +$28.2K ﹤0.01% 3659
2016
Q3 		– Sell
-1,300
Closed -$7K – 5023
2016
Q2 		$7K Sell
1,300
-5,200
-80% -$33.2K ﹤0.01% 4200
2016
Q1 		$35K Sell
6,500
-7,700
-54% -$44.8K ﹤0.01% 3464
2015
Q4 		$124K Buy
14,200
+6,200
+78% +$52.3K ﹤0.01% 2846
2015
Q3 		$67K Buy
8,000
+7,000
+700% +$111K ﹤0.01% 3345
2015
Q2 		$18K Sell
1,000
-14,900
-94% -$191K ﹤0.01% 4081
2015
Q1 		$184K Buy
+15,900
New +$184K ﹤0.01% 2436

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Group One Trading's SRNE Position: Q4 2020 in Review

Group One Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2020, closing a stake of 3,697 shares — an estimated $29.7K sold.

Group One Trading first reported a position in SRNE in Q1 2015 and held it in 15 quarters. The position peaked at $391K in Q3 2018. 219 funds tracked by Wall St. Rank hold SRNE as of Q4 2020.

  • Group One Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Group One Trading sold 3,697 Sorrento Therapeutics, Inc. shares in Q4 2020, an estimated $29.7K.
  • Group One Trading first reported a position in Sorrento Therapeutics, Inc. in Q1 2015 and held it in 15 quarters.
  • Group One Trading's Sorrento Therapeutics, Inc. position peaked at $391K in Q3 2018.
  • 219 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2020.

Based on Group One Trading's 13F filing for Q4 2020, filed 10 Feb 2021.